Contraceptive efficacy of oral contraceptives under real life conditions: The impact of a 24-day regimen on contraceptive effectiveness

被引：0
|
作者：
Dinger, Juergen [1 ]
Assmann, Anita [1 ]
Altmann, Mathias [1 ]
机构：
[1] ZEG Ctr Epidemiol & Hlth Res, Berlin, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
236
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 36 条
  • [1] The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 μg and ethinylestradiol 15 μg
    Bocci, A.
    Spielniann, D.
    Azzini, Pr
    Guaschino, Pr
    Affronti, G.
    Villani, Pr
    Boselli, Pr
    Genazzani, Pr
    Flamigni, Z. C.
    Omodei, U.
    Bolis, P.
    Marsoni, V.
    Luerti, M.
    Simenel, J. L.
    Ouvry-Neveu, B.
    Andre, G.
    David, S.
    Durand, J. L.
    Ehret-Mentre, C.
    Gensburger, J. M.
    Goetzmann, P.
    Jung-Faerber, S.
    Keller, D.
    Lempereur, M.
    Plumere, C.
    Spielmann, A.
    Katz, J. L.
    Sebaoun, J.
    Belaisch, J.
    Hammer, F.
    Salama, B.
    Aissaoui, S.
    Taube, A. M.
    Nakache, H.
    Soria, J.
    Joffo, M.
    Lardenois, H.
    Leclerc, P.
    Ponsar, C.
    Saubry-Bobet, V.
    Blaiset, E.
    Veyres, F.
    Clamp, M.
    Menon, K. V. K.
    Moran, D. G.
    Randall, S.
    Shaw, P. J.
    Bruni, V.
    Massobrio, M.
    Crosignani, P.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 1999, 4 : 9 - 15
  • [2] VTE Risk in Users of Combined Oral Contraceptives: Impact of a 24-Day Regimen Containing Drospirenone
    Reed, Suzanne
    Bardenheuer, Kristina
    Dinger, Juergen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 169 - 170
  • [3] CYCLE CONTROL WITH A 21-VS. A 24-DAY ORAL CONTRACEPTIVE REGIMEN: INFLUENCE OF PREVIOUS HORMONAL EXPOSURE
    Kaunitz, A.
    Fisher, A.
    LaGuardia, K.
    CONTRACEPTION, 2009, 80 (02) : 204 - 204
  • [4] Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg (Loestrin® 24 Fe)
    Nakajima, Steven T.
    Archer, David F.
    Ellman, Herman
    CONTRACEPTION, 2007, 75 (01) : 16 - 22
  • [5] Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg given for 24 days compared to a 21-day regimen.
    Ellman, H
    Archer, DF
    FERTILITY AND STERILITY, 2005, 84 : S169 - S170
  • [6] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill A Randomized Controlled Trial
    Kaunitz, Andrew M.
    Burkman, Ronald T.
    Fisher, Alan C.
    LaGuardia, Katherine D.
    OBSTETRICS AND GYNECOLOGY, 2009, 114 (06): : 1205 - 1212
  • [7] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill: A Randomized Controlled Trial
    Richman, Susan
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (04): : 866 - 867
  • [8] Bleeding profile of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg compared to a 21-day regimen.
    Ellman, H
    Archer, DF
    FERTILITY AND STERILITY, 2005, 84 : S171 - S171
  • [9] Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
    Bachmann, G
    Sulak, PJ
    Sampson-Landers, C
    Benda, N
    Marr, J
    CONTRACEPTION, 2004, 70 (03) : 191 - 198
  • [10] THE RISK OF VENOUS THROMBOEMBOLISM IN USERS OF A DROSPIRENONE-CONTAINING ORAL CONTRACEPTIVE WITH A 24-DAY REGIMEN - RESULTS FROM THE INAS-OC STUDY.
    Dinger, J.
    Bardenheuer, K.
    Moehner, S.
    FERTILITY AND STERILITY, 2010, 94 (04) : S3 - S3
1234